397 filings
Page 6 of 20
6-K
BNTX
BioNTech SE
4 Nov 22
Current report (foreign)
5:00pm
20-F/A
2021 FY
BNTX
BioNTech SE
26 Oct 22
Annual report (foreign) (amended)
5:20pm
6-K
BNTX
BioNTech SE
19 Oct 22
Current report (foreign)
6:27pm
6-K
BNTX
BioNTech SE
13 Oct 22
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
5:58pm
6-K
BNTX
BioNTech SE
12 Oct 22
Current report (foreign)
5:17pm
6-K
BNTX
BioNTech SE
26 Sep 22
Current report (foreign)
7:18am
6-K
BNTX
BioNTech SE
16 Sep 22
Current report (foreign)
4:20pm
6-K
BNTX
BioNTech SE
12 Sep 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union
4:13pm
6-K
BNTX
BioNTech SE
9 Sep 22
BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO
4:41pm
6-K
BNTX
BioNTech SE
7 Sep 22
BioNTech CEO Ugur Sahin Visited Israel to Discuss Cooperation on Pandemic Preparedness and the Development of Innovative Medicines
6:56am
6-K
BNTX
BioNTech SE
2 Sep 22
Current report (foreign)
9:15am
6-K
BNTX
BioNTech SE
1 Sep 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
5:38pm
6-K
BNTX
BioNTech SE
31 Aug 22
Current report (foreign)
5:08pm
6-K
BNTX
BioNTech SE
26 Aug 22
Statement on Patent Infringement Lawsuit Filed by Moderna
5:02pm
6-K
BNTX
BioNTech SE
26 Aug 22
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine
4:53pm
6-K
BNTX
BioNTech SE
23 Aug 22
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
8:56am
6-K
BNTX
BioNTech SE
22 Aug 22
Current report (foreign)
5:23pm
6-K
BNTX
BioNTech SE
8 Aug 22
Unaudited Interim Condensed Consolidated Financial Statements
7:17am
6-K
BNTX
BioNTech SE
8 Aug 22
BioNTech Announces Second Quarter Financial Results and Corporate Update
7:16am
6-K
BNTX
BioNTech SE
5 Aug 22
BioNTech and Genmab Expand Global Strategic Collaboration to Develop and Commercialize Novel Immunotherapy Candidates
6:49am